SYNERGETIC PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF DIABETES MELLITUS

FIELD: medicine, endocrinology, pharmacy. ^ SUBSTANCE: invention relates to drugs and concerns a synergetic pharmaceutical composition comprising the following components: (a) the first pharmaceutical composition containing antidiabetic active component chosen from group consisting of insulin, metfo...

Full description

Saved in:
Bibliographic Details
Main Authors SIL'VASHI ZOL'TAN, LITERATI NAD' PETER, RABLOTSKI D'ERDI
Format Patent
LanguageEnglish
Russian
Published 10.12.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract FIELD: medicine, endocrinology, pharmacy. ^ SUBSTANCE: invention relates to drugs and concerns a synergetic pharmaceutical composition comprising the following components: (a) the first pharmaceutical composition containing antidiabetic active component chosen from group consisting of insulin, metformin and glyburide, or antihyperlipidemic active component chosen from group consisting of lovastatin and simvastatin, and one or more standard carriers, and (b) the second pharmaceutical composition comprising O-(3-piperidino-2-hydroxy-1-propyl)-nicotinamidoxime or its pharmaceutically acceptable salt and one or more standard carriers. Proposed pharmaceutical composition is useful for prophylaxis or treatment of insulin-resistance, metabolic X-syndrome or diabetes mellitus of type 2. The proposed composition possesses high effectiveness in lower doses that results to reducing toxicity treatment. ^ EFFECT: improved and valuable medicinal properties of composition. ^ 3 cl, 5 tbl
AbstractList FIELD: medicine, endocrinology, pharmacy. ^ SUBSTANCE: invention relates to drugs and concerns a synergetic pharmaceutical composition comprising the following components: (a) the first pharmaceutical composition containing antidiabetic active component chosen from group consisting of insulin, metformin and glyburide, or antihyperlipidemic active component chosen from group consisting of lovastatin and simvastatin, and one or more standard carriers, and (b) the second pharmaceutical composition comprising O-(3-piperidino-2-hydroxy-1-propyl)-nicotinamidoxime or its pharmaceutically acceptable salt and one or more standard carriers. Proposed pharmaceutical composition is useful for prophylaxis or treatment of insulin-resistance, metabolic X-syndrome or diabetes mellitus of type 2. The proposed composition possesses high effectiveness in lower doses that results to reducing toxicity treatment. ^ EFFECT: improved and valuable medicinal properties of composition. ^ 3 cl, 5 tbl
Author LITERATI NAD' PETER
SIL'VASHI ZOL'TAN
RABLOTSKI D'ERDI
Author_xml – fullname: SIL'VASHI ZOL'TAN
– fullname: LITERATI NAD' PETER
– fullname: RABLOTSKI D'ERDI
BookMark eNqNyjsKg0AQgOEtkiKvO8wFAlGLYDlZx7iwL3ZH0EokbKqggrk_SZEDpPr54N-LzTRPaSe62FsKd2IlwTcYDEpqv0AN0hnvomLlLNQugA_ON73GTkVAWwEHQjZkGVwNlcIbMUUwpLXiNh7F9jm-1nT69SCgJpbNOS3zkNZlfKQpvYfQ5kWWlZerzIs_lg8fyzNH
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate СИНЕРГИЧНЫЙ ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ПРОФИЛАКТИКИ ИЛИ ЛЕЧЕНИЯ ДИАБЕТА
ExternalDocumentID RU2311907C2
GroupedDBID EVB
ID FETCH-epo_espacenet_RU2311907C23
IEDL.DBID EVB
IngestDate Fri Jul 19 13:09:10 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Russian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_RU2311907C23
Notes Application Number: RU20040105149
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071210&DB=EPODOC&CC=RU&NR=2311907C2
ParticipantIDs epo_espacenet_RU2311907C2
PublicationCentury 2000
PublicationDate 20071210
PublicationDateYYYYMMDD 2007-12-10
PublicationDate_xml – month: 12
  year: 2007
  text: 20071210
  day: 10
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies N-DZHIN RESERCH LABORATORIZ INK
RelatedCompanies_xml – name: N-DZHIN RESERCH LABORATORIZ INK
Score 2.6896915
Snippet FIELD: medicine, endocrinology, pharmacy. ^ SUBSTANCE: invention relates to drugs and concerns a synergetic pharmaceutical composition comprising the following...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title SYNERGETIC PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF DIABETES MELLITUS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071210&DB=EPODOC&locale=&CC=RU&NR=2311907C2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFA9DRb3pVJxf5CC9FV2btvZQpEtTW7EfpKl0p9FuHeyyja3Df9-Xsk0vegsJPJIHv_eVvF8QetRsAqDRiUrqulKJRWzVnk511bCnhlkbdqVNZKNwFJtBTt4Lo-ig2a4XpuUJ_WrJEQFRY8B709rr5U8Ry2vfVq6fqhlMLV594XjKLju2JB-W4g0cliZeQhVKHZ4rMXcgjAHXZ1Gw1ocQRVsSDOxzIJtSlr89in-GjlIQNm_OUWe16aITuvt4rYuOo-19Nwy30FtfoCIbxoy_MRFSnAYuj1zKciHZDDBNojTJQllswpDU4ZQnaTD8cIsww27sYcGZKyRpP0587IXugAmW4YhBHi_y7BJhnwkaqLDF0V4dI57vD6NfoYP5Yl5fI2yUWlmC1p_JxATHNClL_cUcy6KvOe73TbuHen-Kufln7RadtuXMvgYW-w4dNKtNfQ9-uKkeWg1-A0H6hhk
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG-IGvGmqBE_ezC7Lco-3WExo-vclH2k68w4kQ1GwgUIjPjv-7oAetFb0yYv7Ut-76t9vyL0qFgagEbVZK2qSlkzNUu2plNV1q2pblS6VSoT0SgcRoafae-5nrfQbNcL0_CEfjXkiICoMeC9buz18qeI5TZvK9dP5QymFq8et11plx2bgg9Lcvs2TWI3JhIhNsukiNkQxoDrMwlY60OIsE0BBvrZF00py98exTtFRwkIm9dnqLXadFCb7D5e66DjcHvfDcMt9NbnKE-HEWVvlAcEJ77DQofQjAs2A0ziMInTQBSbMCR1OGFx4g8HTh6k2IlczBl1uCDtx7GH3cDpU05THFLI43mWXiDsUU58GbY42qtjxLL9YdRLdDBfzKsrhPVCKQrQ-rM2McAxTYpCfTHGouhrjHs9w-qi7p9irv9Ze0Btn4eD0SCIPm7QSVPa7ClgvW_RQb3aVHfgk-vyvtHmN7iEiQw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SYNERGETIC+PHARMACEUTICAL+COMPOSITION+FOR+PROPHYLAXIS+AND+TREATMENT+OF+DIABETES+MELLITUS&rft.inventor=SIL%27VASHI+ZOL%27TAN&rft.inventor=LITERATI+NAD%27+PETER&rft.inventor=RABLOTSKI+D%27ERDI&rft.date=2007-12-10&rft.externalDBID=C2&rft.externalDocID=RU2311907C2